Anti-EGFR antibody drug conjugates

The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs. Formula (IIa), (IIb), (IIc)

Saved in:
Bibliographic Details
Main Authors Boghaert, Erwin R, Judd, Andrew S, Bruncko, Milan, Phillips, Andrew C, Souers, Andrew J
Format Patent
LanguageEnglish
Published 03.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to anti-Epidermal Growth Factor Receptor (EGFR) antibody drug conjugates (ADCs) which inhibit Bcl-xL, including compositions and methods of using said ADCs. Formula (IIa), (IIb), (IIc)
Bibliography:Application Number: AU20170277517